Introduction
Abdominal aortic aneurysm (AAA) can be defined as an aortic diameter greater than 1.5 times its normal calibre and is a significant burden on healthcare globally 1 . In the 20 th century, AAA was a disease on the rise, with evidence of a steady increase in aneurysm incidence and mortality in the United Kingdom (UK) 2 and the United States of America (USA) 3 . This triggered randomised trials of ultrasound screening of AAA in an effort to address the AAA epidemic, which revealed the benefit of screening in reducing deaths from AAA related mortality 4, 5 .
However, contemporary data from western populations 6 have reported a reversal in AAA epidemiology, with steep declines in AAA incidence and mortality during the 21 st Century. It is possible that these observations are secondary to changes in population trends of known cardiovascular risk factors such as cigarette smoking and blood pressure however no large population based evidence of this currently exists.
Although several risk factors for AAA have been identified, smoking is the only modifiable risk factor that has been associated with the development, expansion 7, 8 and rupture of AAA 9 with a causative link recently being revealed in vivo within a mouse model 10 . A decline in smoking is likely to have contributed significantly to the current reversal of the AAA epidemic 11 however this trend is not the same across the world where recent decades have seen a massive expansion in tobacco use and accelerating growth in smoking among women in the developed world 12 . Global trends in AAA mortality are currently unclear and variations in these trends will provide a valuable opportunity to determine underlying factors associated with the disease. This study aims to examine global trends in AAA mortality and investigate the link between smoking and other common cardiovascular risk factors with AAA mortality.
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Smoking Data
The availability of smoking prevalence data for each year varied between countries however ISS3 is the largest validated international smoking statistics dataset available and these differences have been taken into account within the analysis.
Risk factor data
Risk factor data was extracted from the World Health Organisation (WHO) infobase 14 17 , especially in older adults ( 55 years), in whom most deaths from cardiovascular disease occur.
Countries included
After exclusion of countries based on completeness of statistics and availability of risk factor data the following 19 countries were included into this study: Australia, Austria, Canada, Denmark, Finland, France, Germany, Hungary, Iceland, Israel, Japan, Netherlands, New
Zealand, Norway, Romania, Spain, Sweden, UK and USA.
Statistics
Men and women were analysed separately. Risk factor data including mean total cholesterol; mean fasting blood glucose; mean body mass index; mean systolic blood pressure and prevalence of smoking were plotted over all available time points from which slopes of the 01/09/2012. Each risk factor was presented as an age standardised estimate in ea ac ch ch d d def ef efin in ined ed ed n population in both males and females. Systolic blood pressure (SBP) was analysed, rather than di ias as sto to toli li lic c bl bl bloo oo ood pr pr re es ess sure (DBP), because prospect ct ctiv ive e studies strong ng ngly s sug ug ugge g st that SBP is a better pred d dic i tor of car ardi d d o o ovas ascu cu ula la lar r r di di dis se seas ase e e ri ri r sk kregression lines of the variable against time were calculated with robust standard errors.
Similarly ASM was plotted over all available time points from which slopes of the regression lines against time were calculated with robust standard errors.
The data were analysed by a linear errors-in-variables regression (Supplemental file 1), a model which allows for uncertainty in both the response and explanatory variables namely; AAA mortality and the risk factors respectively. In contrast, standard regression models assume that those regressors have been observed without error therefore, account only for errors in the dependent variables, or responses 18 . The standard errors of variables such as the rate of change in smoking prevalence with time were calculated separately from the data for each country and then those standard errors were treated as known when fitting the regression model, as previously published by Deming 19 . The models were fitted by maximum likelihood using the ml command in Stata12 (StataCorp, TX, USA). Significance was assessed using likelihood ratio tests. A delayed deaths analysis was performed for each country. Total unadjusted (male and female)
AAA deaths per year were compared between two age groups for each country included in the analysis (deaths due to AAA in individuals under 75 years of age and deaths due to AAA in those 75 years of age and over). The proportion of deaths in the two age groups and the change in these proportions over time was calculated for each individual country.
Results

Trends in AAA mortality
This study reveals substantial heterogeneity in AAA ASM trends globally although male and
female AAA mortality appears to be declining in most populations (Fig 1a and b) . The USA, UK and Australia appear to have the fastest declining male AAA ASM at 6.7%, 6.2% and 6.2%
hose standard errors were treated as known when fitting the regression model, as as s p pre r r vi vi viou ou ousl sl sly y y published by Deming 19 . The models were fitted by maximum likelihood using the ml command n n S S Sta ta tata ta ta12 12 per year respectively. The largest reductions in female AAA mortality were seen in the UK and USA at 4% and 3.9% per year respectively therefore, it appears that the rate of decline in female AAA mortality is less than for male. Importantly AAA mortality is not declining globally as evidenced by an increase in male AAA ASM in Hungary (2.7%) and Romania (1.7%) and in female AAA ASM in Hungary (3.5%), Romania (1%), Denmark (2.2%) and Austria (0.5%).
Some countries appear to have a declining AAA mortality in males and an increasing AAA mortality in females for example Denmark and Austria.
Although mortality is decreasing in both the over and under 75 age groups, the percentage decrease appears to be greatest in the under 75 age group. In the UK <75 mortality 
Trends in risk factors
Temporal trends in the common cardiovascular risk factors show a significant amount of heterogeneity across the countries studied. 
The association of trends in AAA mortality to trends in risk factors
Regression analysis suggests that trends in systolic blood pressure (Fig 2a, P=0 .028), cholesterol (Fig 3a, P=0 .0082) and smoking prevalence (Fig 4a, P=0 .017) are positively and significantly associated with changes in male AAA mortality while trends in BMI (Fig 5a, P=0 .0072) are negatively and significantly associated with changes in male AAA mortality. Similarly in females, trends in systolic blood pressure (Fig 2b, P=0 .024), cholesterol (Fig 3b, P=0 .024) and smoking prevalence (Fig 4b, P=0 .00021) were positively and significantly associated with AAA mortality whilst trends in BMI were negatively and significantly associated with AAA mortality (Fig 5b, P=0.0039 ). The direction of the AAA mortality trend was in both males and females Canada (-4.1% per year) and Spain (-3.4% per year) whilst the smallest reduction on n w w was s s see ee een n n in in in Hungary (-1.3% per year). Only one country was seen to have an increasing male smoking trend R Rom om oman an ania ia ia, , +0 +0 +0.6% % % p pe per year). The largest increase e es s s in n n female smok k kin in i g pr pr pre ev evalence were seen in S Sp Spa ai ain n and Roma mani nia at at t + +1 1 1.4% 4% 4% a a and nd + +1 1.5 5 5 p p per y y yea a ar eac ac ach h wh wh whil ilst st t t the he h l l lar r rge est st t d de ecl clin in ine e e wa wa as se se s e en i i in n c cel el elan an nd d d (-(-( 3. 3. .5% 5% 5% p p per r r y yea ear) r) ). 
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Discussion
Between 1951 and 1995 epidemiological studies revealed that AAA was a disease on the rise, with a steady increase in aneurysm incidence and mortality in the UK 2 and USA 3 . However, more recently, evidence from a number of countries suggests that 6, 20 during the 21 st century a reversal in AAA epidemiology has occurred, with steep declines in AAA incidence and mortality. This study represents the largest population based analysis of AAA mortality to date and confirms that AAA mortality is declining in most developed economies; however that decline is not equal between countries, gender or age groups. In addition this is the first large population based study to demonstrate a relationship between global variations in common cardiovascular risk factors and AAA mortality suggesting that public health measures to reduce the incidence of hypertension, high cholesterol and smoking could reduce global AAA mortality further.
Male and female AAA mortality is generally declining however the rate of decline is not equal with the UK and USA appearing to show the steepest drop in AAA mortality (male and female) whilst Romania and Hungary both show increases in AAA mortality across both genders. Male AAA mortality appears to be declining more sharply than female although in some countries an increasing trend in female AAA mortality has been seen with the reverse in males. This finding may reflect differences in risk factor exposure for example smoking trends are not the same across the world where recent decades have seen a general decline in male mortality. This study represents the largest population based analysis of AAA mo mo ort tal al a it it ty y y to to to d d dat at a e e and confirms that AAA mortality is declining in most developed economies; however that de ecl cl clin in ine e e i is is n n not ot ot equ qu ua al al between countries, gender o o or r r ag g ge groups. In a add d d it tio io on n n this is the first large pop pu pulation bas ased ed ed s s stu udy dy d t t to o de de demo mo m ns ns str tr trat at a e e e a a rela a ati i ions sh hi ip p b b bet et twe we een n n g gl lo ob ba bal l v va ar ri iat atio io ion ns ns i in n n co co omm mm mo on on ca ard rd rdio io iova va v sc scul ul ular ar r ri is isk k k fa fac c cto or ors s an n nd d AA AA AAA A A mo mo mort rt rtal al ali ity y y su su sugg gg ges es sti ting ng ng t th that at at p pub ub ubli li lic c c h h hea al alth th h m m mea ea e su su sur r res to to r red ed duc c ce e
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Tobacco use is the single most important preventable health risk in the developed world, with well-established links to the development, expansion and rupture of AAA 7-9 likely orchestrated by nicotine as evidenced by the findings of recent in vivo mouse model studies 10 . This study demonstrates a strongly linear relationship between temporal trends in smoking prevalence and AAA mortality.
It is known that sexual dimorphism exists amongst a number of cardiovascular diseases 21 , therefore it is possible that the pathophysiology of AAA development is different in females who have been noted to have a fourfold higher rupture rate 22 compared to males. In addition to the observed differences between genders, the percentage decline in AAA mortality appears to be more profound in the under 75 age group. This finding has previously been shown in the UK 20 which in addition to an observed increase in the number of elective admissions for AAA in the > 75 age group may suggest that improvements in public health do not prevent AAA but instead slow down the development of AAA in genetically predisposed individuals.
The finding that an elevated BMI may be associated with a decrease in AAA mortality is novel however needs to be interpreted with caution. The association between traditional cardiovascular risk factors and an improvement in clinical outcomes has been observed in those with heart failure and chronic obstructive lung disease [23] [24] [25] with this association referred to as 'reverse epidemiology' or more recently the 'obesity paradox' however whether a raised BMI actually confers any survival advantage on patients with AAA remains to be proven. Sweeting et al 22 revealed that an increased BMI was associated with a slower rate of AAA growth however that this affect was lost after adjustment for demographics including medical history and drug history. A recent population-based cohort study 26 associated with the risk of AAA however BMI was not. BMI is thought to reflect total adiposity, whereas waist circumference is an approximate index of intra-abdominal fat mass, which corresponds well to visceral adiposity therefore it may be that visceral adiposity rather than total adiposity is important in the development of AAA. Smoking cessation has long been linked with weight gain 27 therefore one possible explanation for the obesity paradox is that countries with the greatest reduction in smoking prevalence may have increases in obesity but a decline in AAA mortality.
Whilst the association between obesity and AAA is unclear, epidemiological studies have demonstrated obesity as an independent risk factor for type II diabetes 28 and studies thus far appear to suggest a protective role for diabetes on the development of AAA 22, 29 which may explain this observation. This study found no significant association between global trends in fasting glucose concentrations and AAA mortality which may suggest that the protective effect of diabetes is not secondary to changes in fasting glucose concentrations however this requires further investigation. One explanation for the lack of any association between AAA mortality and fasting glucose may be counteraction, with an increased mortality post AAA repair in diabetics 30 concealing any benefit gained from slower AAA development however, whether diabetes confers any survival disadvantage on patients post AAA repair is currently unclear 31 .
Obesity is more common in economically developed countries therefore economical factors such as health expenditure could account for some of the differences observed in this study and it is of interest to note that the UK spent 9.3% of its gross domestic product on health expenditure in 2011 whilst the USA, Romania and Hungary spent 17.9%, 5.8% and 7.7% respectively 32 .
Our results do not exclude the possibility of other factors influencing population trends in AAA mortality for example the exponential increase in prescriptions of antihypertensive and appear to suggest a protective role for diabetes on the development of AAA 22, 29 9 w w whi hi h ch ch h m m may ay ay explain this observation. This study found no significant association between global trends in fa ast st tin in ing g g l gl gluc uc ucos os se co co con nc ncentrations and AAA mortalit it ity y w which may su ugg gg g es st t t t th ha hat the protective effect of f d d dia i betes is n not ot t s s sec co on onda da dary r ry t t to o o ch chan an ange ges s i i in fa a ast ting gl lucos os ose e c co on nc ncen en ntr r rat atio ion ns ns h how ow owev ever er r t thi hi his s re e eq qu quir ir ire es s fu urt rt rthe he her r r in inve ve est st stig iga at tio o on. n. O On ne ne exp xp pla la an n nat at atio io ion n fo fo or r r th th the la la lack ck k o o of a an any y y a a as ssoc oc ocia ia ati ion on on b b bet twe wee en en A A AAA AA AA m m mor or rta tali lit t ty and fasting gl gl gluc uc ucos os se e e ma ma may y y be e e c c cou ou o nt nt nter er e ac ac a ti i ion on on, , wi wi with th th an an an i inc nc n re e eas as ased ed ed m m mor or orta tali li lit ty y y po po post st st A AAA AA AA r rep ep epai a r in lipid lowering medication or the epidemic of type II diabetes effecting most developed economies however these effects are taken into account in that they effect population distributions of each relevant risk factor. Changes in the treatment of AAA have occurred during the study period as since the introduction of endovascular aneurysm repair (EVAR), it has become established as the treatment of choice for most suitable patients in many vascular centres. However a recent meta-analysis 33 revealed no long-term survival benefit for patients undergoing EVAR compared to open surgery suggesting that this paradigm shift should not influence overall mortality trends. Other limitations of this study include the use of civil registration system mortality information from which completeness of data varies between countries and that AAA mortality has over time risen and fallen 20, [34] [35] [36] (not behaved linearly)
however, the time points included into this study occur within the mortality decline for many of the countries included and the analysis performed takes into account both of these limitations.
Mortality from aortic rupture can be missed unless autopsy is carried out therefore it is possible that AAA mortality is underestimated however this should affect all included countries equally.
Conclusion
This study provides robust evidence that AAA mortality is not declining globally and that a linear relationship appears to exist with worldwide trends in systolic blood pressure, cholesterol, smoking prevalence and BMI. The importance of this finding is that public health measures to address these common cardiovascular risk factors could be applied in countries with an increasing AAA trend. The delay that risk factor modification appears to have on age at AAA mortality may represent a delay in the presentation of clinically relevant AAA which would have implications for the future of AAA screening.
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SUPPLEMENTAL MATERIAL
Errors in Variables Regression
A simple regression model of y on x can be expressed as,
where εi is a normally distributed random error with constant variance that represents all of the unmeasured sources of variation that make y deviate from its trend line. It is implicit in this model that x is measured without error.
In our analysis both x and y represent quantities estimated from annual data reported by each country. For example, x might be the annual increase or decrease in average blood pressure over a given time interval. These quantities are estimated with error and for each country we have both an estimate of x and of its standard error and similarly we have an estimate of y and its standard error. If μx and μy represent the true values of the quantities that are being estimated then we assume that
So it is the true levels of the quantities that are linearly related. Further we assume that the estimated value of x ~ N(μx,σx) where σx is the standard error and is assumed known.
Similarly y ~ N(μy,σy). We then assume that the estimates of x and y are independent since they come from different surveys. Finally we assume that the variation about the trend line, in excess of the measurement error in y, has a constant variance. This model is similar to that used by Pocock et al 1 (1981) and is an example of an error in variables model in which the variances of the errors in x and y are assumed known.
The model was fitted by maximum likelihood in Stata12 (StataCorp, TX) using the ml command. For the examples considered in this paper convergence of the Newton-Raphson algorithm was very quick. The significance of a particular x was tested by fitting the model described above and then fitting the same model but with β1=0. The models were compared in a likelihood ratio test.
Supplemental figure 1a -Linear Regression revealing the association between trends in FBG and trends in male AAA mortality (P =0.306).
Supplemental figure 1b -Linear regression revealing the association between trends in FBG and trends in female AAA mortality (p =0.958). 
